VanEck Genomics and Healthcare Innovators UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.35 %TER
£17.83M Fund size
49Number of positions
— TD
61.45 %Top 10 share
USDCurrency
5SRI

Diversification

Here you can find the number of holdings and the composition of the index constituents of the VanEck Genomics and Healthcare Innovators UCITS ETF.

Holdings55
Stock positions49
Bond positions0
Cash and other positions6
% of assets in top 10 positions61.45 %

Market capitalisation

Here you can see the percentage breakdown of the VanEck Genomics and Healthcare Innovators UCITS ETF by market capitalisation. Market capitalisation reflects the current stock market value of a publicly listed company.

Very large—
Large22.50 %
Mid-cap45.97 %
Small26.76 %
Micro4.78 %

Portfolio metrics

These are the forecasts for the portfolio metrics as well as value and growth rates of the VanEck Genomics and Healthcare Innovators UCITS ETF.

Portfolio metrics (forecast)
Price-to-earnings ratio (P/E)
20.65
Price-to-book ratio (P/B)
3.87
Dividend yield
0.11 %
Price/cash flow ratio
16.31
Price/sales ratio
5.49
Value and growth rates (forecast)
Book value growth
-1.06 %
Cash flow growth
22.28 %
Hist. earnings growth
12.66 %
Long-term estimated earnings growth
8.80 %
Revenue growth
7.37 %

Equity investment style

The extraETF investment style box is a highly useful tool for portfolio construction. The box classifies the VanEck Genomics and Healthcare Innovators UCITS ETF along the vertical axis by market capitalisation and along the horizontal axis by value and growth characteristics.

9.85 % 10.32 % 2.33 % 1.08 % 14.09 % 30.80 % 3.15 % 13.74 % 14.64 %
Large
22.50 %
Medium
45.97 %
Small
31.54 %
Market capitalisation
Value
14.08 %
Blend
38.15 %
Growth
47.77 %
Stock style
At 30.80 %, Growth stocks with a medium market capitalisation represent the largest portfolio share.

Risk metrics

Here you can find important risk metrics for the VanEck Genomics and Healthcare Innovators UCITS ETF.

Volatility
25.17 %
Max. drawdown
-14.99 %
Sharpe Ratio
1.02
Treynor Ratio
40.92 %
Information Ratio
0.52 %
Correlation to benchmark
43.92 %
Capture Ratio Up
99.97
Capture Ratio Down
14.08
Batting Average
41.67 %
Alpha
16.18 %
Beta
0.75
R2
19.29 %
Benchmark
Morningstar Gbl Health NR USD
As of
31 Oct 2026

Would you like to use this feature and unlock the full potential of your investments?

Register now on extraETF.com and get unlimited access to all data & features.
Create portfolios, watchlists and price alerts, and use our professional-grade investment analysis.

Sign up now

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.